News and events
10x health technology from Finland
Tekniikan Maailma features ten Finnish health technology companies providing innovative solutions for the benefit of the patient – Adamant Health with its unique measurement and analysis service for Parkinson's disease being one of them.
WANTED: Director of Finance and Operations
As the Director of Finance and Operations, you will play a critical role in shaping the financial and operational strategies of Adamant Health. This position offers a unique blend of financial management and operational involvement, making it ideal for those who thrive in a dynamic and evolving environment.
World Parkinson's Day 2024
Today is World Parkinson's Day, a day dedicated to raising awareness for the disease and paying tribute to people living with the condition every day! Parkinson’s disease is the fastest-growing neurological disorder in the world, affecting people of all races and cultures.
Parkinson's Awareness Month 2024
April marks Parkinson’s Awareness Month, a time dedicated to increasing awareness about and elevating the conversation around Parkinson's disease, a neurological disorder that progressively impairs movement and function, affecting millions worldwide.
Bringing research to the benefit of people suffering from Parkinson’s disease
On Saturday, we had the honor to celebrate the Finnish Movement Disorders Association’s 40th anniversary together with over 200 guests, including people diagnosed with movement disorders and their relatives.
Wanted: Software Developer – Cloud backend
Are you passionate about software development? Do you seek a meaningful job to help people suffering from Parkinson’s disease? We are looking for a Software Developer to join our diverse and passionate team of professionals to revolutionize the care of Parkinson's disease.
Season's greetings 2023
2023 has been an exciting year for Adamant Health. With the year drawing to an end, we’d like to take this opportunity to thank you for your cooperation and support. As we pause to spend time with family and friends during the holidays, we wish you a happy, healthy holiday season and a wonderful New Year!
World Movement Disorders Day 2023
Movement disorders can be especially difficult to diagnose, treat, and understand. In the next 30 years, there will be a strong increase in the number of people affected by movement disorders and that is why we are promoting #MoveDisorder awareness.
New study on wearable monitoring of negative myoclonus available
A new study on wearable monitoring of negative myoclonus within the home environment is now available. The research was conducted in collaboration between the University of Eastern Finland, Kuopio University Hospital (KUH) - Kuopion yliopistollinen sairaala (KYS), UCL Queen Square Institute of Neurology and Adamant Health.
Adamant Health has developed a unique method for measuring the symptoms of Parkinson's patients
Adamant Health has developed a technology and service that will revolutionize the care of Parkinson's disease and other movement disorders. Business Kuopio has interviewed Adamant Health's founders Paulus Carpelan and Saara Rissanen.
Wanted: Software Developer - Mobile
Adamant Health is growing and entering a new phase in its journey, and we are looking for a Software Developer to strengthen our team. In this role you are developing mobile applications enabling our unique Parkinson’s disease measurement, connecting data to our cloud service, and communicating analyzed information back to the patient.
Adamant Health selected for Deep Tech Accelerator funding program
Adamant Health secures funding from Business Finland's Deep Tech Accelerator program for rapid market entry and targeted growth on international markets. The Deep Tech Accelerator funding will serve as a catalyst in accelerating Adamant Health's entry to selected European markets and drive our growth, particularly within our target customer segments.
Adamant Health’s project co-funded by the European Union
Adamant Health’s project focusing on better understanding Parkinson’s disease patients’ lives at home is co-funded by the European Union.
Adamant Health team is growing
After several successful recruitments during spring 2023, Adamant Health's team has been growing. Meet our team of 14 professionals dedicated to revolutionise the care of Parkinson's disease!
April is Parkinson’s Awareness Month
April marks Parkinson’s Awareness Month, an opportunity to increase awareness about the condition and a time to acknowledge the tremendous strength and resilience of people living with the disease and to celebrate the contributions of individuals and organizations supporting efforts to find effective treatments and improve the management Parkinson’s disease.
New office opened in Kuopio
Adamant Health has opened an office at Hub Panostamo in KPY Novapolis, Kuopio.
Adamant Health participated in the UEF Startup Day
Adamant Health participated with its growing team in the UEF Startup Day at the University of Eastern Finland on 19 January 2023.
We’re hiring!
Are you looking to put your professional expertise to good use by helping people suffering from severe chronic conditions to live a better life? Are you in your element at a fast-growing startup, where you have the opportunity to truly make a change? Do you wish to further develop healthcare systems to serve those in need? If this sounds like you, we’d love to hear from you!
New analytics transform the treatment of movement disorders
The treatment of Parkinson’s disease is currently based on short doctor’s appointments arranged a few times per year, during which patients talk about their symptoms and the doctor makes observations on the patient. As the symptoms may vary from day to day, prescribing medications based on appointments alone is challenging.
A new service for the evaluation of movement disorders
Adamant Health Ltd is a health technology company founded in 2020 and it has its roots in medical physics research at the University of Eastern Finland. The company has developed a new measurement and analysis service to support evaluation of movement disorders, such as the symptoms of Parkinson’s disease and myoclonus-epilepsies. Neurocenter Finland has supported the product development.